Certara, Inc. (NASDAQ:CERT) Given Average Rating of “Hold” by Analysts

Shares of Certara, Inc. (NASDAQ:CERT) have earned a consensus rating of “Hold” from the eleven ratings firms that are covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $20.06.

CERT has been the subject of several research analyst reports. Jefferies Financial Group boosted their price objective on Certara from $14.00 to $15.50 and gave the company a “hold” rating in a research report on Friday, March 1st. Leerink Partnrs reissued a “market perform” rating on shares of Certara in a research report on Monday, February 26th. UBS Group boosted their price objective on shares of Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a research report on Friday, March 1st. KeyCorp upgraded Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price for the company in a report on Wednesday, April 10th. Finally, SVB Leerink began coverage on Certara in a research note on Monday, February 26th. They issued a “market perform” rating and a $19.00 price target on the stock.

Certara Stock Up 3.1 %

Shares of NASDAQ:CERT opened at $17.08 on Thursday. The company has a 50 day moving average price of $17.67 and a two-hundred day moving average price of $16.29. The company has a market capitalization of $2.74 billion, a PE ratio of -48.80, a PEG ratio of 1.71 and a beta of 1.63. Certara has a 52 week low of $11.81 and a 52 week high of $24.64. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.62 and a current ratio of 2.62.

Certara (NASDAQ:CERT) last released its quarterly earnings data on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). The firm had revenue of $88.01 million during the quarter, compared to the consensus estimate of $86.80 million. Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. Analysts forecast that Certara will post 0.29 earnings per share for the current year.

Insider Buying and Selling

In other Certara news, insider Patrick F. Smith sold 14,427 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total value of $243,094.95. Following the completion of the transaction, the insider now directly owns 50,091 shares in the company, valued at $844,033.35. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Certara news, insider Patrick F. Smith sold 14,427 shares of the stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the completion of the sale, the insider now owns 50,091 shares in the company, valued at $844,033.35. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Richard M. Traynor sold 6,000 shares of Certara stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $18.00, for a total transaction of $108,000.00. Following the completion of the transaction, the senior vice president now directly owns 165,368 shares of the company’s stock, valued at approximately $2,976,624. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 23,427 shares of company stock worth $405,095. Corporate insiders own 2.39% of the company’s stock.

Institutional Trading of Certara

Hedge funds have recently made changes to their positions in the business. Pineridge Advisors LLC acquired a new position in shares of Certara during the 4th quarter worth approximately $28,000. Global Retirement Partners LLC increased its holdings in shares of Certara by 5,306.3% in the first quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock valued at $31,000 after purchasing an additional 1,698 shares during the last quarter. YHB Investment Advisors Inc. bought a new position in shares of Certara in the first quarter valued at about $47,000. Covestor Ltd lifted its stake in shares of Certara by 14,940.0% during the 3rd quarter. Covestor Ltd now owns 3,760 shares of the company’s stock worth $55,000 after buying an additional 3,735 shares during the last quarter. Finally, Gamco Investors INC. ET AL acquired a new position in Certara in the 3rd quarter valued at about $145,000. 73.96% of the stock is owned by institutional investors and hedge funds.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.